Mutated in Colorectal Cancers (MCC) (AA 88-103) Peptide

Catalog No. ABIN399611

Product Details

Target: MCC (Mutated in Colorectal Cancers (MCC))

Protein Region: AA 88-103

Purification: Rabbit Anti-IGF-1R (Phospho-Tyr1165, 1166) Polyclonal Antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatogramphy using non-phosphopeptide corresponding to the phosphorylation site.

Purity: > 95 %

Application Details

Restrictions: For Research Use only

Handling

Storage: -20 °C

References

Cheng, Wang, Ye, Huang, Liu, Wu, Sun, Xie, Wang, Xia: "'Default' generated neonatal regulatory T cells are hypomethylated at conserved non-coding sequence 2 and promote long-term cardiac allograft survival." in: Immunology, Vol. 143, Issue 4, pp. 618-30, (2014) (PubMed).

Gollmer, Asperti-Boursin, Tanaka, Okkenhaug, Vanhaesebroeck, Peterson, Fukui, Donnadieu, Stein: "CCL21 mediates CD4+ T-cell costimulation via a DOCK2/Rac-dependent pathway." in: Blood, Vol. 114, Issue 3, pp. 580-8, (2009) (PubMed).

Target Details

Target: MCC (Mutated in Colorectal Cancers (MCC))

Synonyms: MCC Peptide, mcc1 Peptide, MCC1 Peptide, D18Ertd451e Peptide, E330037C19 Peptide, RGD1561988 Peptide, mutated in colorectal cancers Peptide, MCC Peptide, mcc Peptide, Mcc Peptide

Background: This peptide is derived from the carboxyl terminus of moth cytochrome c. Thymic positive and negative selections govern the development of a self-MHC-reactive, yet self-tolerant, T cell repertoire. Cytochrome c MCC (88-103) plays major role in T-cell selection.